Foghorn Therapeutics Inc. Diluted Shares Outstanding (Weighted Average)
Foghorn Therapeutics Inc. (FHTX) reported Diluted Shares Outstanding (Weighted Average) of 70.63 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 70.63M shares, a 12.15% increase year-over-year.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 69.54M shares, a 10.65% increase year-over-year.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 63.07M shares, a 0.31% increase year-over-year.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 63.03M shares, a 0.68% increase year-over-year.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 62.98M shares, a 14.72% increase from fiscal 2024.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 54.90M shares, a 30.79% increase from fiscal 2023.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 41.97M shares, a 0.92% increase from fiscal 2022.
- Foghorn Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 41.59M shares, a 11.89% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 70.63M shares 10-Q · filed 2026-08-06 | 70.09M shares 10-Q · filed 2026-08-06 | 67.75M shares derived: average of 3 quarters · filed 2026-08-06 | 66.57M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 69.54M shares 10-Q · filed 2026-05-07 | 66.30M shares derived: average of 2 quarters · filed 2026-05-07 | 65.21M shares derived: average of 3 quarters · filed 2026-05-07 | 64.65M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 63.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 63.05M shares derived: average of 2 quarters · filed 2026-03-11 | 63.02M shares derived: average of 3 quarters · filed 2026-08-06 | 62.98M shares 10-K · filed 2026-03-11 |
| 2025-09-30 | 63.03M shares 10-Q · filed 2025-11-05 | 63.00M shares derived: average of 2 quarters · filed 2026-08-06 | 62.95M shares 10-Q · filed 2025-11-05 | 62.93M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 62.98M shares 10-Q · filed 2026-08-06 | 62.91M shares 10-Q · filed 2026-08-06 | 62.90M shares derived: average of 3 quarters · filed 2026-08-06 | 62.83M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 62.85M shares 10-Q · filed 2026-05-07 | 62.86M shares derived: average of 2 quarters · filed 2026-05-07 | 62.77M shares derived: average of 3 quarters · filed 2026-05-07 | 59.98M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 62.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 62.74M shares derived: average of 2 quarters · filed 2026-03-11 | 59.02M shares derived: average of 3 quarters · filed 2026-03-11 | 54.90M shares 10-K · filed 2026-03-11 |
| 2024-09-30 | 62.60M shares 10-Q · filed 2025-11-05 | 57.09M shares derived: average of 2 quarters · filed 2025-11-05 | 52.24M shares 10-Q · filed 2025-11-05 | 49.71M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 51.58M shares 10-Q · filed 2025-08-05 | 47.00M shares 10-Q · filed 2025-08-05 | 45.41M shares derived: average of 3 quarters · filed 2025-08-05 | 44.57M shares derived: average of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | 42.43M shares 10-Q · filed 2025-05-14 | 42.33M shares derived: average of 2 quarters · filed 2025-05-14 | 42.23M shares derived: average of 3 quarters · filed 2025-05-14 | 42.13M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 42.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 42.13M shares derived: average of 2 quarters · filed 2025-03-06 | 42.03M shares derived: average of 3 quarters · filed 2025-03-06 | 41.97M shares 10-K · filed 2025-03-06 |
| 2023-09-30 | 42.03M shares 10-Q · filed 2024-11-04 | 41.93M shares derived: average of 2 quarters · filed 2024-11-04 | 41.89M shares 10-Q · filed 2024-11-04 | 41.87M shares derived: average of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | 41.83M shares 10-Q · filed 2024-08-08 | 41.82M shares 10-Q · filed 2024-08-08 | 41.81M shares derived: average of 3 quarters · filed 2024-08-08 | 41.78M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 41.81M shares 10-Q · filed 2024-05-06 | 41.81M shares derived: average of 2 quarters · filed 2024-05-06 | 41.76M shares derived: average of 3 quarters · filed 2024-05-06 | 41.70M shares derived: average of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | 41.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 41.74M shares derived: average of 2 quarters · filed 2024-03-07 | 41.66M shares derived: average of 3 quarters · filed 2024-03-07 | 41.59M shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 41.67M shares 10-Q · filed 2023-11-02 | 41.59M shares derived: average of 2 quarters · filed 2023-11-02 | 41.52M shares 10-Q · filed 2023-11-02 | 40.65M shares derived: average of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | 41.52M shares 10-Q · filed 2023-08-04 | 41.44M shares 10-Q · filed 2023-08-04 | 40.31M shares derived: average of 3 quarters · filed 2023-08-04 | 39.48M shares derived: average of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | 41.37M shares 10-Q · filed 2023-05-08 | 39.71M shares derived: average of 2 quarters · filed 2023-05-08 | 38.80M shares derived: average of 3 quarters · filed 2023-05-08 | 38.31M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 38.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 37.51M shares derived: average of 2 quarters · filed 2023-03-09 | 37.29M shares derived: average of 3 quarters · filed 2023-03-09 | 37.17M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 36.97M shares 10-Q · filed 2022-11-08 | 36.91M shares derived: average of 2 quarters · filed 2022-11-08 | 36.88M shares 10-Q · filed 2022-11-08 | 34.59M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 36.85M shares 10-Q · filed 2022-08-09 | 36.83M shares 10-Q · filed 2022-08-09 | 33.80M shares derived: average of 3 quarters · filed 2022-08-09 | 26.82M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 36.82M shares 10-Q · filed 2022-05-09 | 32.27M shares derived: average of 2 quarters · filed 2022-08-09 | 23.48M shares derived: average of 3 quarters · filed 2022-08-09 | 18.96M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | 27.73M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | 16.80M shares derived: average of 2 quarters · filed 2022-08-09 | 13.01M shares derived: average of 3 quarters · filed 2022-08-09 | 11.05M shares 10-K/A · filed 2022-08-09 |
| 2020-09-30 | 5.88M shares 10-Q · filed 2021-11-09 | 5.65M shares derived: average of 2 quarters · filed 2021-11-09 | 5.49M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 5.42M shares 10-Q · filed 2021-08-10 | 5.29M shares 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |